Immediate-type hypersensitivity to polyethylene glycols: a review

Clinical and Experimental Allergy

Volumn 46, Issue 7, 2016, Pages 907-922

  Wenande, E ^a   Garvey, L H ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL DERIVATIVE;

ALLERGY; CHEMICAL STRUCTURE; CLINICAL FEATURE; EXPOSURE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNITY; IMMUNOLOGIST; MOLECULAR WEIGHT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

EID: 84976489372     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12760     Document Type: Review

References (74)

1. Myler H, Hruska MW, Srinivasan S et al. Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN-lambda-1a and PEG-IFN-alpha2a in naive patients. Bioanalysis 2015; 7:1093–106.
2. Fruijtier-Polloth C. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. Toxicology 2005; 214:1–38.
3. ??? ???. Final report on the safety assessment of polyethylene glycols (PEGs)-6, -8, -32, -75, -150, -14M, -20M. Int J Toxicol 1993; 12:429–57.
4. Harris JM. Introduction to biotechnical and biomedical applications of poly(ethylene glycol). In: Harris JM, eds. Poly(Ethylene Glycol) Chemistry. New York and London: Plenum Press; 1992: 1–20
5. Henning T. Polyethylene glycols (PEGs) and the pharmaceutical industry. FharmaChem 2002; 1:57–9.
6. Chadwick VS, Phillips SF, Hofmann AF. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400. Gastroenterology 1977; 73:241–6.
7. DiPiro JT, Michael KA, Clark BA et al. Absorption of polyethylene glycol after administration of a PEG-electrolyte lavage solution. Clin Pharm 1986; 5:153–5.
8. Zhang H, Henry WA, Chen LA, Khashab MA. Urticaria due to polyethylene glycol-3350 and electrolytes for oral solution in a patient with jejunal nodular lymphoid hyperplasia. Ann Gastroenterol 2015; 28:148–50.
9. Smyth HF, Carpenter CP, Shaffer CB, Seaton J, Fisher L. Some pharmacological properties of polyethylene glycols and high molecular weight (“carbowax” compounds). J Ind Hyg Toxicol 1942; 24:281–4.
10. de Groot AC, Conemans JM. Contact allergy to furazolidone. Contact Dermatitis 1990; 22:202–5.
11. Spoerl D, Scherer K, Bircher AJ. Contact urticaria with systemic symptoms due to hexylene glycol in a topical corticosteroid: case report and review of hypersensitivity to glycols. Dermatology 2010; 220:238–42.
12. Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem 2010; 49:6288–308.
13. Pevny I, Uhlich M. [Allergy against components of medical and cosmetic external preparations. Polyethylene glycol, propylene glycol, hexantriole]. Hautarzt 1975;26:252–4.
14. Hyry H, Vuorio A, Varjonen E, Skytta J, Makinen-Kiljunen S. Two cases of anaphylaxis to macrogol 6000 after ingestion of drug tablets. Allergy 2006; 61:1021.
15. Bommarito L, Mietta S, Nebiolo F, Geuna M, Rolla G. Macrogol hypersensitivity in multiple drug allergy. Ann Allergy Asthma Immunol 2011; 107:542–3.
16. Kwee NDJ. Anaphylaxis to polyethylene glycol (peg) in a multivitamin tablet. J Allergy Clin Immunol 1962; 69:409–12.
17. Hesselbach C, Bohning W, Wettengel R. [Anaphylactic shock after sucking on a throat lozenge]. Dtsch Med Wochenschr 1990; 115:1397–9.
18. Schuman E, Balsam PE. Probable anaphylactic reaction to polyethylene glycol electrolyte lavage solution. Gastrointest Endosc 1991; 37:411.
19. Co-Minh HB, Demoly P, Guillot B, Raison-Peyron N. Anaphylactic shock after oral intake and contact urticaria due to polyethylene glycols. Allergy 2007; 62:92–3.
20. Dewachter P, Mouton-Faivre C. Anaphylaxis to macrogol 4000 after a parenteral corticoid injection. Allergy 2005; 60:705–6.
21. Denham DDJ. Polyethylene glycol (Peg 3350)-induced anaphylaxis: a case report. South Med J 1992; 44:209–10.
22. Henriquez-Santana A, Fernandez-Guarino M, Gonzalez de Olano D et al. Urticaria induced by etoxisclerol (polidocanol). J Eur Acad Dermatol Venereol 2008; 22:261–2.
23. Guilleminault LRE, Carr P, Hoarau C. Positive skin test to pegylated drug in a patient with anaphylaxis to polyethylene glycol. Revue Francais D'Allergologie 2012; 52:45–7.
24. Savitz JA, Durning SJ. A rare case of anaphylaxis to bowel prep: a case report and review of the literature. Mil Med 2011; 176:944–5.
25. Shah S, Prematta T, Adkinson NF, Ishmael FT. Hypersensitivity to polyethylene glycols. J Clin Pharmacol 2013; 53:352–5.
26. Wenande E, Kroigaard M, Mosbech H, Garvey LH. Polyethylene glycols (PEG) and related structures: overlooked allergens in the perioperative setting. A A Case Rep 2015; 4:61–4.
27. Wenande EC, Skov PS, Mosbech H, Poulsen LK, Garvey LH. Inhibition of polyethylene glycol-induced histamine release by monomeric ethylene and diethylene glycol: a case of probable polyethylene glycol allergy. J Allergy Clin Immunol 2013; 131:1425–7.
28. Bordere A, Stockman A, Boone B et al. A case of anaphylaxis caused by macrogol 3350 after injection of a corticosteroid. Contact Dermatitis 2012; 67:376–8.
29. Yamasuji Y, Higashi Y, Sakanoue M et al. A case of anaphylaxis caused by polyethylene glycol analogues. Contact Dermatitis 2013; 69:183–5.
30. Pizzimenti S, Heffler E, Gentilcore E et al. Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. J Allergy Clin Immunol Pract 2014; 2:353–4.
31. Sohy C, Vandenplas O, Sibille Y. Usefulness of oral macrogol challenge in anaphylaxis after intra-articular injection of corticosteroid preparation. Allergy 2008; 63:478–9.
32. Gachoka D. Polyethylene glycol (PEG)-induced anaphylactic reaction during bowel preparation. ACG Case Rep J 2015; 2:216–7.
33. Lee SH, Cha JM, Lee JI et al. Anaphylactic shock caused by ingestion of polyethylene glycol. Intest Res 2015; 13:90–4.
34. Ito M, Watanabe D, Kobayashi M, Tamada Y, Matsumoto Y. Acute hypersensitivity to dentifrice. Contact Dermatitis 2006; 54:225.
35. Assal C, Watson PY. Angioedema as a hypersensitivity reaction to polyethylene glycol oral electrolyte solution. Gastrointest Endosc 2006; 64:294–5.
36. Pariente EA, Piot M, Delvert D, Benichou M, Barbe S. [Asthma and skin rash after preparation to colonoscopy with a flavored polyethylene glycol solution]. Gastroenterol Clin Biol 1992; 16:614–5.
37. Thiaucourt D, Bigard MA. [Asthma and bronchospasm during a preparation for colonoscopy with polyethylene glycol aromatized solution]. Gastroenterol Clin Biol 1993; 17:230–1.
38. Lesur G, Chetrit B, Granveau A, Turner LDupuy P. [Allergic reaction during preparation for colonoscopy]. Gastroenterol Clin Biol 1994; 18:537–8.
39. Badiu I, Guida G, Heffler E, Rolla G. Multiple drug allergy due to hypersensitivity to polyethylene glycols of various molecular weights. J Investig Allergol Clin Immunol 2015; 25:368–9.
40. Jakubovic BD, Saperia C, Sussman GL. Anaphylaxis following a transvaginal ultrasound. Allergy Asthma Clin Immunol 2016; 12:3.
41. Fisher AA. Contact urticaria due to polyethylene glycol. Cutis 1977; 19:409–12.
42. Fisher AA. Immediate and delayed allergic contact reactions to polyethylene glycol. Contact Dermatitis 1978; 4:135–8.
43. Antolin-Amerigo D, Sanchez-Gonzalez MJ, Barbarroja-Escudero J et al. Allergic reaction to polyethylene glycol in a painter. Occup Med (Lond) 2015; 65:502–4.
44. Almer S, Franzen L, Olaison G, Smedh K, Strom M. Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis. Gut 1993; 34:509–13.
45. Seidman EG, Hanson DG, Walker WA. Increased permeability to polyethylene glycol 4000 in rabbits with experimental colitis. Gastroenterology 1986; 90:120–6.
46. Camarasa JM. Acute contact urticaria. Contact Dermatitis 1982; 8:347–8.
47. Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensitivity. Lancet 1995; 345:1312–3.
48. Lieberman P. The unusual suspects: a surprise regarding reactions to omalizumab. Allergy Asthma Proc 2007; 28:259–61.
49. Perez-Perez L, Garcia-Gavin J, Pineiro B, Zulaica A. Biologic-induced urticaria due to polysorbate 80: usefulness of prick test. Br J Dermatol 2011; 164:1119–20.
50. Badiu I, Geuna M, Heffler E, Rolla G Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80. BMJ Case Rep 2012;2012, 1–2
51. Coors EA, Seybold H, Merk HF, Mahler V. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann Allergy Asthma Immunol 2005; 95:593–9.
52. Limaye S, Steele RH, Quin J, Cleland B. An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity. J Allergy Clin Immunol 2002; 110:530.
53. Price KS, Hamilton RG. Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy. Allergy Asthma Proc 2007; 28:313–9.
54. Li Z, Ji F, Zheng Y, An J, Peng Z. Pegylated interferon, but not conventional interferon therapy induced severe skin lesions. Ann Hepatol 2012; 11:570–1.
55. Meller S, Erhardt A, Auci A, Neumann NJ, Homey B. [Drug-induced exanthema caused by pegylated interferon-alpha 2b]. Hautarzt 2003;54:992–3.
56. Veldt BJ, Schalm SW, Janssen HL. Severe allergic eczema due to pegylated alpha-interferon may abate after switching to daily conventional alpha-interferon. J Clin Gastroenterol 2007; 41:432.
57. Meller S, Gerber PA, Kislat A et al. Allergic sensitization to pegylated interferon-alpha results in drug eruptions. Allergy 2015; 70:775–83.
58. Sakatani A, Doi Y, Matsuda T et al. Protracted anaphylaxis developed after peginterferon alpha-2a administration for chronic hepatitis C. World J Gastroenterol 2015;21:2826–9.
59. Poreaux C, Bronowicki JP, Debouverie M et al. Clinical allergy. Managing generalized interferon-induced eruptions and the effectiveness of desensitization. Clin Exp Allergy 2014;44:756–64.
60. Hamad I, Hunter AC, Szebeni J, Moghimi SM. Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process. Mol Immunol 2008; 46:225–32.
61. Richter AW, Akerblom E. Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors. Int Arch Allergy Appl Immunol 1984; 74:36–9.
62. Garay RP, El-Gewely R, Armstrong JK, Garratty G, Richette P. Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. Expert Opin Drug Deliv 2012; 9:1319–23.
63. Anton GM, Roan RJ, de la Hoz B, Sanchez Cano M. Immediate allergic reactions by polyethylene glycol 4000: two cases. Allergol Immunopathol 2008;36:110–2.
64. Garvey LH, Kroigaard M, Poulsen LK et al. IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 2007; 120:409–15.
65. Ito K, Sato S, Urisu A et al. An evaluation of spontaneous histamine release and the low responders in a basophil histamine release test. Arerugi 2016; 65:48–56.
66. Prieto A, Baeza ML, Herrero T et al. Contact dermatitis to Furacin. Contact Dermatitis 2006; 54:126.
67. Strauss MJ. Sensitization to polyethylene glycols, carbowaxes. Arch Derm Syphilol 1950; 61:420–5.
68. Moreno Escobosa MC, Moya Quesada MC, Cruz Granados S, Amat Lopez J. Contact dermatitis to antibiotic ointments. J Investig Allergol Clin Immunol 2009;19:510–1.
69. Guijarro SC, Sanchez-Perez J, Garcia-Diez A. Allergic contact dermatitis to polyethylene glycol and nitrofurazone. Am J Contact Dermatitis 1999; 10:226–7.
70. Gaul LE. Sensitization to polyethylene glycol and furacin. Med Times 1953; 81:424–5.
71. Lee JSCH, Chug WC, Kim SS, Song HJ, Lee KM. Urticaria reaction by oral polyethylene glycol ingestion. Korean J Gastrointest Endosc 2002; 24:299–301.
72. Stollman N, Manten HD. Angioedema from oral polyethylene glycol electrolyte lavage solution. Gastrointest Endosc 1996; 44:209–10.
73. Brullet E, Moron A, Calvet X, Frias C, Sola J. Urticarial reaction to oral polyethylene glycol electrolyte lavage solution. Gastrointest Endosc 1992; 38:400–1.
74. Coschieri M, Philippon A, Longo F et al. Urticaria after ingestion of polyethylene glycol. Gastroenterol Clin Biol 1994; 18:538.